Mycotopia Therapies Announces Plan to Develop Psychedelic Sublingual Tablet to Help Treat Depression
Mycotopia Therapies (TPIA) and Agile Pharmaceutical Solutions formed a joint venture to develop an oral psilocybin tablet for depression. The companies may work with HAVN Life Sciences (HAVN) in Jamaica for assistance with development and sourcing materials.